![Dana Hilt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dana Hilt
Technik-/Wissenschafts-/F&E-Leiter bei
ACTINOGEN MEDICAL LIMITED
Vermögen: 974 000 $ am 30.09.2026
Profil
Dr. Dana C.
Hilt, MD, is a Chief Medical Officer at Actinogen Medical Ltd. Dr. Hilt was previously employed as a Chief Medical Officer by Frequency Therapeutics, Inc., a Chief Medical Officer by Lysosomal Therapeutics, Inc., a Chief Medical Officer by Critical Therapeutics, Inc., a Chief Medical Officer & SVP-Drug Development by FORUM Pharmaceuticals, Inc., a Director-Clinical Neurosciences by Amgen, Inc., a Chief Medical Officer by Ascend Pharmaceuticals, Inc., a Chief Medical Officer & SVP-Clinical Research by ASCEND Therapeutics US LLC, a Chief Medical Officer by Brenig Therapeutics, Inc., and a Vice President-Clinical Research by Guilford Pharmaceuticals, Inc. He received his undergraduate degree from the University of Maine and a doctorate degree from Tufts University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.08.2025 | 25.000.000 ( 0,65 % ) | 974 000 $ | 30.09.2026 |
Aktive Positionen von Dana Hilt
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 |
Ehemalige bekannte Positionen von Dana Hilt
| Unternehmen | Position | Ende |
|---|---|---|
Brenig Therapeutics, Inc.
 Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Technik-/Wissenschafts-/F&E-Leiter | 10.06.2025 |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Technik-/Wissenschafts-/F&E-Leiter | 25.09.2007 |
ASCEND Therapeutics US LLC
 ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Technik-/Wissenschafts-/F&E-Leiter | - |
| KORRO BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dana Hilt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinogen Medical Ltd.
 Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Ascend Pharmaceuticals, Inc. | |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
